Abeona Therapeutics Inc. (0H7R.L)

USD 5.88

(-2.0%)

Inventory Summary of Abeona Therapeutics Inc.

  • Abeona Therapeutics Inc.'s latest annual inventory in 2023 was -2.44 Million USD , down 0.0% from previous year.
  • Abeona Therapeutics Inc.'s latest quarterly inventory in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Abeona Therapeutics Inc. reported annual inventory of - USD in 2022, down -100.0% from previous year.
  • Abeona Therapeutics Inc. reported annual inventory of 1.00 USD in 2021, down 0.0% from previous year.
  • Abeona Therapeutics Inc. reported quarterly inventory of - USD for 2024 Q1, down 0.0% from previous quarter.
  • Abeona Therapeutics Inc. reported quarterly inventory of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Inventory Chart of Abeona Therapeutics Inc. (2023 - 2012)

Historical Annual Inventory of Abeona Therapeutics Inc. (2023 - 2012)

Year Inventory Inventory Growth
2023 -2.44 Million USD 0.0%
2022 - USD -100.0%
2021 1.00 USD 0.0%
2020 - USD 0.0%
2019 - USD -100.0%
2018 1.00 USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 1.00 USD 0.0%
2014 - USD -100.0%
2013 1.00 USD -100.0%
2012 194 Thousand USD 0.0%

Peer Inventory Comparison of Abeona Therapeutics Inc.

Name Inventory Inventory Difference
Editas Medicine, Inc. - USD Infinity%
Dynavax Technologies Corporation 53.29 Million USD 104.586%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 103.157%
Perrigo Company plc 1.14 Billion USD 100.214%
Illumina, Inc. 587 Million USD 100.416%
Thermo Fisher Scientific Inc. 5.08 Billion USD 100.048%
Iovance Biotherapeutics, Inc. 10.37 Million USD 123.563%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 100.029%
IQVIA Holdings Inc. - USD Infinity%
Heron Therapeutics, Inc. 42.11 Million USD 105.804%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 100.095%
Unity Biotechnology, Inc. - USD Infinity%
Waters Corporation 516.23 Million USD 100.473%
Biogen Inc. 2.52 Billion USD 100.097%
Sangamo Therapeutics, Inc. - USD Infinity%
Evolus, Inc. 10.99 Million USD 122.222%
Adicet Bio, Inc. - USD Infinity%
Cara Therapeutics, Inc. 2.82 Million USD 186.636%
bluebird bio, Inc. 22.91 Million USD 110.664%
Esperion Therapeutics, Inc. 65.62 Million USD 103.724%
FibroGen, Inc. 41.56 Million USD 105.88%
Agilent Technologies, Inc. 1.03 Billion USD 100.237%
Corbus Pharmaceuticals Holdings, Inc. - USD Infinity%
Homology Medicines, Inc. - USD Infinity%
Geron Corporation - USD Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 102.742%
Amicus Therapeutics, Inc. 59.69 Million USD 104.094%
Myriad Genetics, Inc. 20.1 Million USD 112.159%
Viking Therapeutics, Inc. - USD Infinity%
Intellia Therapeutics, Inc. - USD Infinity%
Zoetis Inc. 2.56 Billion USD 100.095%
Mettler-Toledo International Inc. 385.86 Million USD 100.633%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 100.221%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 100.331%
Kala Pharmaceuticals, Inc. - USD Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD 108.598%
Atara Biotherapeutics, Inc. 9.7 Million USD 125.18%
Verastem, Inc. - USD Infinity%
Nektar Therapeutics 16.1 Million USD 115.179%
Axsome Therapeutics, Inc. 15.13 Million USD 116.148%
Aclaris Therapeutics, Inc. - USD Infinity%
Sarepta Therapeutics, Inc. 322.85 Million USD 100.757%
OPKO Health, Inc. 65.69 Million USD 103.72%
Exelixis, Inc. 17.32 Million USD 114.108%
Neurocrine Biosciences, Inc. 38.3 Million USD 106.381%
Corcept Therapeutics Incorporated 7.73 Million USD 131.617%
Anavex Life Sciences Corp. - USD Infinity%
uniQure N.V. 12.02 Million USD 120.326%
Imunon, Inc. - USD Infinity%
Blueprint Medicines Corporation 21.22 Million USD 111.516%
Insmed Incorporated 83.24 Million USD 102.936%
Halozyme Therapeutics, Inc. 127.6 Million USD 101.915%
Agios Pharmaceuticals, Inc. 19.07 Million USD 112.812%
TG Therapeutics, Inc. 39.82 Million USD 106.137%
Incyte Corporation 62.97 Million USD 103.881%
Emergent BioSolutions Inc. 328.9 Million USD 100.743%